Integrin alpha 2 (ITGA2) Antikörper

Details zu Produkt Nr. ABIN2480690
Antigen
Reaktivität
Human
246
133
31
19
11
11
10
3
3
3
3
2
1
1
1
1
Wirt
Maus
131
116
81
8
1
Klonalität (Klon)
Monoklonal ()
Konjugat
Unkonjugiert
47
31
31
16
6
5
5
5
5
3
3
3
3
2
2
2
2
2
2
Applikation
Flow Cytometry (FACS), Immunoprecipitation (IP), ELISA
196
118
78
77
31
31
21
19
13
10
9
4
3
3
2
1
Optionen
Immunogen Purified human b1 integrin preparation from HT1080 fibrosarcoma cell extract.
Klon 31H4
Isotyp IgG1
Produktmerkmale Purified IgG
Reinigung Purified
Antigen
Andere Bezeichnung CD49b (ITGA2 Antibody Abstract)
Hintergrund Synonyms: INTEGRIN ALPHA 2 CHAIN, VLA-2
Gen-ID 3673
UniProt P17301
Pathways CXCR4-mediated Signaling Events, Smooth Muscle Cell Migration, Integrin Complex
Applikations-hinweise Optimal working dilution should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1.0 mg/mL
Produkt verwendet in: Tanaka, Toujima, Toyoda, Takeuchi, Umesaki: "Establishment and characterization of novel human uterine leiomyosarcoma cell lines." in: International journal of oncology, Vol. 37, Issue 1, pp. 125-31, 2010 (PubMed).

Tanaka, Wang, Umesaki: "Remodeling of the human endometrial epithelium is regulated by laminin and type IV collagen." in: International journal of molecular medicine, Vol. 23, Issue 2, pp. 173-80, 2009 (PubMed).

Tanaka, Bai, Yukawa, Utsunomiya, Umesaki: "Reduced radiosensitivity and increased CD40 expression in cyclophosphamide-resistant subclones established from human cervical squamous cell carcinoma cells." in: Oncology reports, Vol. 14, Issue 4, pp. 941-8, 2005 (PubMed).